4 Pancreatic Cancer Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Pancreatic Cancer Studies in San Francisco

NCT07252232Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only....

San Francisco, CAPHASE3500 participantsRevolution Medicines, Inc.

View Study Details

NCT05968326Recruiting

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

The purpose of this study is to evaluate the efficacy and safety of adjuvant autogene cevumeran plus atezolizumab and modified leucovorin, 5-fluorouracil (5-FU), irinotecan, and oxaliplatin (mFOLFIRIN...

San Francisco, CAPHASE2260 participantsGenentech, Inc.

View Study Details

NCT05058846Recruiting

Pilot Study of Pancreatic Cancer Screening

This study investigates how often abnormal findings from routine magnetic resonance imaging occur in people with genetic mutations in BReast CAncer gene. (BRCA), ataxia telangiectasia mutated gene (AT...

San Francisco, CA250 participantsUniversity of California, San Francisco

View Study Details

NCT07033689Recruiting

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

This is a feasibility, safety, tolerability, and efficacy research study of an investigational device called "Suizenji", an ultrasound-guided high-intensity focused ultrasound (HIFU) therapy system fo...

San Francisco, CAEARLY_PHASE110 participantsSONIRE Therapeutics Inc.

View Study Details

About Pancreatic Cancer Clinical Trials in San Francisco

Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.

There are currently 4 pancreatic cancer clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 1,020 participants. Research is being sponsored by Revolution Medicines, Inc., Genentech, Inc., University of California, San Francisco and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pancreatic Cancer Clinical Trials in San Francisco — FAQ

Are there pancreatic cancer clinical trials in San Francisco?

Yes, there are 4 pancreatic cancer clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What pancreatic cancer treatments are being tested?

The 4 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.

Data updated July 17, 2026 from ClinicalTrials.gov